| scholarly article | Q13442814 |
| P50 | author | Erin L Meyer | Q80629177 |
| P2093 | author name string | J Michael McIntosh | |
| Doju Yoshikami | |||
| P2860 | cites work | The substantia nigra and its relations with the striatum in the monkey | Q28246714 |
| Nicotinic receptors and Parkinson's disease | Q28377091 | ||
| Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice | Q28506626 | ||
| Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse | Q28508736 | ||
| Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice | Q28586513 | ||
| Neural systems of reinforcement for drug addiction: from actions to habits to compulsion | Q29547251 | ||
| Predictive reward signal of dopamine neurons | Q29615397 | ||
| Getting formal with dopamine and reward | Q29618725 | ||
| Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra | Q31813959 | ||
| Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum | Q34102291 | ||
| Cholinergic interneuron characteristics and nicotinic properties in the striatum | Q34159449 | ||
| Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy | Q34457512 | ||
| Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum | Q34615972 | ||
| Involvement of nicotinic acetylcholine receptors in the protection of dopamine terminals in experimental parkinsonism | Q34628358 | ||
| Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. | Q34717418 | ||
| Nicotine and nicotinic receptors; relevance to Parkinson's disease | Q34995021 | ||
| Neural mechanisms of reward-related motor learning | Q35602987 | ||
| Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release | Q35779572 | ||
| Meaningful silences: how dopamine listens to the ACh pause | Q36380354 | ||
| Phasic dopamine signaling during behavior, reward, and disease states | Q36448729 | ||
| Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system | Q36607367 | ||
| Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development | Q36671758 | ||
| Advances in the treatment of Parkinson's disease | Q36720216 | ||
| Nicotine neuroprotection against nigrostriatal damage: importance of the animal model | Q36782419 | ||
| Principles of voltammetry and microelectrode surface states | Q40865294 | ||
| Neuronal nicotinic acetylcholine receptors | Q41067261 | ||
| Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. | Q42440283 | ||
| Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor | Q43582677 | ||
| Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels | Q43645447 | ||
| A cellular mechanism of reward-related learning. | Q43729267 | ||
| Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum | Q43875891 | ||
| Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions | Q43964639 | ||
| Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. | Q44067046 | ||
| Firing modes of midbrain dopamine cells in the freely moving rat. | Q44120311 | ||
| Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. | Q44185954 | ||
| Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice | Q44403747 | ||
| Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies | Q44524230 | ||
| The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. | Q44681098 | ||
| Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors | Q44814797 | ||
| Frequency-dependent modulation of dopamine release by nicotine | Q44898075 | ||
| Nicotine amplifies reward-related dopamine signals in striatum | Q44898077 | ||
| Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. | Q44904935 | ||
| Effect of novel alpha-conotoxins on nicotine-stimulated [3H]dopamine release from rat striatal synaptosomes | Q45021791 | ||
| Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion | Q45305089 | ||
| Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure | Q46399860 | ||
| The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay | Q46425255 | ||
| Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. | Q46450404 | ||
| Involvement of the dorsal striatum in cue-controlled cocaine seeking. | Q46715134 | ||
| Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro | Q47941797 | ||
| The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems | Q48180144 | ||
| The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. | Q48180155 | ||
| Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey | Q48278964 | ||
| Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum | Q48434978 | ||
| Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin | Q48491137 | ||
| Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. | Q48658270 | ||
| Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons. | Q51373078 | ||
| Electrophysiological and pharmacological evidence for the existence of distinct subpopulations of nigrostriatal dopaminergic neuron in the rat | Q68015991 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| striatum | Q1319792 | ||
| acetylcholine | Q180623 | ||
| P304 | page(s) | 1761-1769 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | The neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slices | |
| P478 | volume | 105 |
| Q84599556 | A novel series of [3.2.1] azabicyclic biaryl ethers as α3β4 and α6/4β4 nicotinic receptor agonists |
| Q33621205 | Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors |
| Q30413058 | Analysis of rare variations reveals roles of amino acid residues in the N-terminal extracellular domain of nicotinic acetylcholine receptor (nAChR) alpha6 subunit in the functional expression of human alpha6*-nAChRs |
| Q35062688 | Association of the calcyon neuron-specific vesicular protein gene (CALY) with adolescent smoking initiation in China and California |
| Q41636544 | Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence |
| Q36641994 | Born to Lead? A Twin Design and Genetic Association Study of Leadership Role Occupancy |
| Q43081291 | Chipping away at the genetics of smoking behavior. |
| Q36316462 | Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits |
| Q36986365 | Co-administration of ethanol and nicotine: the enduring alterations in the rewarding properties of nicotine and glutamate activity within the mesocorticolimbic system of female alcohol-preferring (P) rats |
| Q37535489 | Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions |
| Q51213421 | Effects of L-theanine on posttraumatic stress disorder induced changes in rat brain gene expression. |
| Q34793270 | Focus on α4β2* and α6β2* nAChRs for Parkinson's Disease Therapeutics |
| Q37046788 | Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum. |
| Q34847679 | Functional nicotinic acetylcholine receptors containing α6 subunits are on GABAergic neuronal boutons adherent to ventral tegmental area dopamine neurons |
| Q48031577 | Genetic variants associated with physical and mental characteristics of the elite athletes in the Polish population. |
| Q38616570 | Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis |
| Q36105359 | Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens |
| Q39850502 | Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function |
| Q37384621 | Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens |
| Q42728501 | Mice expressing the ADNFLE valine 287 leucine mutation of the Β2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function |
| Q35922187 | Modulation of gain-of-function α6*-nicotinic acetylcholine receptor by β3 subunits. |
| Q22252514 | Multiple roles for nicotine in Parkinson's disease |
| Q37508589 | Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q35188119 | Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors |
| Q43099250 | Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. |
| Q35097046 | Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats |
| Q30475334 | Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization |
| Q37132142 | Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors |
| Q27021772 | Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype |
| Q42220091 | Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors |
| Q37199162 | Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment |
| Q30395065 | Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence |
| Q35690145 | Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders |
| Q30370472 | Roles for N-terminal extracellular domains of nicotinic acetylcholine receptor (nAChR) β3 subunits in enhanced functional expression of mouse α6β2β3- and α6β4β3-nAChRs. |
| Q24645468 | Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain |
| Q37369436 | Structural basis for alpha-conotoxin potency and selectivity |
| Q37954299 | Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads |
| Q37916643 | Targeting nicotinic receptors for Parkinson's disease therapy |
| Q53426783 | The interaction of the Chrna5 D398N variant with developmental nicotine exposure. |
| Q28576280 | Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum |
| Q34507023 | Why have tobacco control policies stalled? Using genetic moderation to examine policy impacts |
| Q34309950 | α6β2* and α4β2* Nicotinic Receptors Both Regulate Dopamine Signaling with Increased Nigrostriatal Damage: Relevance to Parkinson's Disease |
| Q35264378 | α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease |
Search more.